Profile: RedHawk Holdings Corp (IDNG.PK)
15 Jul 2019
Redhawk Holdings Corp., formerly Independence Energy Corp., incorporated on November 30, 2005, is a holding company, which through its subsidiaries, is engaged in sale and distribution of medical devices, sale of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services. The Company's segments include Land & Hospitality, Medical Device & Pharmaceutical, and Other Services. The Land & Hospitality, and Other Services segment units operate in the United States. The Medical Device & Pharmaceutical segment operates in the United Kingdom. The Company, through its medical products business unit, sells WoundClot Surgical-Advanced Bleeding Control (WoundClot), the Disintegrator Insulin Needle Destruction Unit (Disintegrator), the Carotid Artery Digital Non-Contact Thermometer and Zonis. The Company's real estate leasing revenues are generated from a commercial property under a long-term lease. The Company's real estate investment unit holds limited liability company interest in a commercial restoration project in Hawaii.
The Thermofinder is a medical grade non-contact thermometer that is distributed in Asia and Europe, and its features include two measuring modes, including body temperature and surface/ambience modes, which allow the reading of air temperature and fluid temperature; Non-invasive design-Operated by pointing and pressing within 3-5 centimeters of the patient's forehead or other target; liquid crystal display (LCD) backlit display with multi-color screen and alert function, and less than two second reading response time. The FS-700 Pro model is equipped with a medical grade protection cover, logo lanyard, anti-microbial option, and rechargeable battery and station. The Company also owns medical products technology, including the tangible and intangible assets, for the Disintegrator. The Disintegrator is a needle destruction device.
The WoundClot product is an implantable surgical hemostat designed to stop moderate to severe arterial and venous hemorrhage without the need to compress directly onto the wound. WoundClot is a single use sterile bio-absorb hemostatic product made of non-oxidized cellulose, which can be fabricated into a variety of forms suitable in controlling bleeding from various kinds of wounds. WoundClot is engineered and manufactured with a molecular structure, designed to entrap platelets and coagulants in a modified physical molecular matrix. WoundClot is a cellulose-based product manufactured using a non-oxidative process. WoundClot has been trialed in various surgery disciplines, including cardiothoracic, hepatobiliary, pediatric neurosurgery, vascular and trauma surgery.
Zonis is an antimicrobial ionic silver calcium catheter dressing with both wound healing and hemostatic properties. Zonis is designed to be placed directly over the exit site of all vascular and non-vascular percutaneous medical devices. Zonis reduces bacteria colonization and related bloodstream infections by delivering ionic silver directly to the site. The markets for the Company's devices and branded generics include retail pharmacies, hospitals, physicians' offices, private and public healthcare clinics, corrections facilities, schools, veterinary clinics, emergency services and long term care facilities. The Company's subsidiaries include RedHawk Medical Products UK Ltd, RedHawk Pharma UK Ltd and RedHawk Land & Hospitality, LLC.
RedHawk Holdings Corp
3753 Pennridge Dr
BRIDGETON MO 63044-1226